A success in Toxinology translational research in Brazil: Bridging the gap

Toxicon

Volumn 69, Issue , 2013, Pages 50-54

  Ferreira, Ana Silvia S B S ^a   Barraviera, Benedito ^a   Barraviera, Silvia Regina C S ^a   Abbade, Luciana P F ^a   Caramori, Carlos Antonio ^a   Ferreira, Rui Seabra ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Fibrin sealant; GAP; Translational potential; Translational research

Indexed keywords

FIBRIN GLUE; VACCINE; FIBRIN; SNAKE VENOM;

ARTICLE; BASIC RESEARCH; BIOMEDICINE; BRAZIL; CLINICAL RESEARCH; DIAGNOSTIC PROCEDURE; DRUG DESIGN; DRUG DEVELOPMENT; EDUCATION PROGRAM; FUNDING; HEALTH PRACTITIONER; HUMAN; INFORMATION PROCESSING; NEGLECTED DISEASE; NONHUMAN; PRIORITY JOURNAL; TOXINOLOGY; TRANSLATIONAL RESEARCH; TROPICS; CLINICAL TRIAL (TOPIC); COMMERCIAL PHENOMENA; DATA BASE; DIAGNOSTIC TEST; DRUG RESEARCH; GOVERNMENT; PUBLIC HEALTH; QUALITY CONTROL; REGISTER; RELIABILITY; TOXICOLOGY; ANIMAL; CHEMISTRY; METHODOLOGY; REPRODUCIBILITY; PROCEDURES;

ANIMALIA;

ANIMALS; BRAZIL; DRUG DISCOVERY; FIBRIN; HUMANS; PUBLIC HEALTH; REPRODUCIBILITY OF RESULTS; SNAKE VENOMS; TOXICOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84878478208     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.01.003     Document Type: Article

References (13)

1. Barros L.C., Ferreira R.S., Barraviera S.R.C.S., Stolf H.O., Thomazini-Santos I.A., Mendes-Giannini M.J.S., Toscano E., Barraviera B. A new fibrin sealant from Crotalus durissus terrificus venom: applications in medicine. Journal of Toxicology and Environmental Health Part B 2009, 12:553-571.
2. Beckett M., Quiter E., Ryan G., Berrebi C., Taylor S., Cho M., Pincus H., Kahn K. Bridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriers. Implementation Science 2011, 6:35.
3. Calixto J.B., Siqueira J.M. The drug development in Brazil: challenges. Gazeta Médica da Bahia 2008, 78(Suplemento 1):98-106. Available at:. http://www.gmbahia.ufba.br/index.php/gmbahia/article/viewFile/269/260.
4. ClinicalTrials.gov. U. S. of Health. Available at: (accessed 29.10.12.). http://www.clinicaltrials.gov.
5. Cooksey D. A Review of UK Health Research Funding 2006, HMSO, London.
6. Ferreira R.S., Mari J.J., Barraviera B. Primeira disciplina de pos-graduação strictu-sensu a distância no Brazil com apoio da Capes 2008, Available at:, (accessed 29.10.12.). http://www.abed.org.br/congresso2008/tc/617200841230PM.pdf.
7. Gatti M.A.N., Vieira L.M., Barraviera B., Barraviera S.R.C.S. Treatment of venous ulcers with fibrin sealant derived from snake venom. The Journal of Venomous Animals and Toxins Including Tropical Diseases 2011, 17:226-229.
8. Kahn K., Ryan G., Beckett M., Taylor S., Berrebi C., Cho M., Quiter E., Fremont A., Pincus H. Implementation Science 2011, 6:34.
9. Light D.W., Warburton R. BioSocieties 2011, 6:34-50.
10. Morgan M., Barry C.A., Donovan J.L., Sandall J., Wolfe D.A., Boaz A. Implementing 'translational' biomedical research: convergence and divergence among clinical and basic scientists. Social Science & Medicine 2011, 73:945-952.
11. Vanscheidt W., Ukat A., Horak V., Brüning H., Hunyadi J., Pavlicek R., Emter M., Hartmann A., Bende J., Zwingers Th., Ermuth T., Eberhardt R. Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant: a multinational randomized controlled clinical trial. Wound Repair and Regeneration 2007, 15:308-315.
12. Venkatesh S., Lipper R.A. Role of the development scientist in compound lead selection and optimization. Journal of Pharmaceutical Sciences 2000, 89(2):145-154.
13. Woolf S.H. The meaning of translational research and why it matters. JAMA 2008, 299(2):211-213.